Beta Betty

The story

Betty takes metoprolol every morning since her heart attack. Today her apical pulse is 54 and she feels lightheaded. She also mentions she sometimes skips doses when she feels fine.

Betty is a retired piano teacher known for her exquisitely precise sense of rhythm, a skill that made her the natural choice years ago to keep the church choir perfectly on beat. After a heart attack left her with reduced cardiac function, her cardiologist started her on metoprolol, a beta blocker that competitively blocks beta-adrenergic receptors to slow her heart rate, reduce contractility, and lower her blood pressure, easing the workload on her damaged heart muscle. Because beta blockers also blunt the sympathetic nervous system's fight-or-flight response, Betty's body loses some of its usual early warning signs for danger, whether that is a racing pulse warning of low blood sugar or the rebound surge that follows abruptly stopping the drug. Her nickname, born of her impeccable timing at the keyboard, becomes an ironic reminder of how precisely timed and monitored beta blocker therapy truly needs to be.

Betty also happens to manage type 2 diabetes with an oral hypoglycemic agent, a combination her nurse flags immediately as needing extra vigilance. One month into her metoprolol regimen, Betty skips lunch before an unusually long grocery trip, distracted by finding ingredients for a new recipe. She feels a bit unsteady and notices she is perspiring more than the mild afternoon warmth would explain, but she does not experience the racing heartbeat or trembling hands she remembers from previous low blood sugar episodes years earlier. Because those adrenergic warning signs are precisely what her beta blocker is designed to suppress, Betty has no idea that her blood glucose is quietly plummeting as she pushes her cart down the cereal aisle.

A store employee finds Betty sitting on a bench, pale, diaphoretic, and having trouble forming complete sentences. Paramedics check her fingerstick glucose and find it at 52 milligrams per deciliter, dangerously low despite her heart rate holding steady at only 58 beats per minute, a rate that would normally have spiked in response to hypoglycemia if her sympathetic response were not blunted. Separately, weeks later, Betty runs out of her metoprolol prescription over a long holiday weekend and, rather than calling for an emergency refill, simply stops taking it, assuming a few missed days will not matter. By the third day off the medication, her heart rate climbs to 118 beats per minute and her blood pressure spikes to 178 over 102, both signs of dangerous rebound sympathetic surge from abrupt beta blocker withdrawal.

The nurse treating Betty's hypoglycemia administers oral glucose immediately and rechecks her fingerstick every fifteen minutes until it stabilizes, then educates her firmly that sweating, not tachycardia, may now be her only reliable warning sign of low blood sugar, and that scheduled glucose checks matter more than ever. When addressing the rebound crisis, the nurse restarts metoprolol promptly and coordinates an emergency prescription refill process for Betty going forward, teaching her explicitly that this medication must always be tapered gradually under medical supervision, never stopped abruptly. Before every future dose in any care setting, the nurse also reinforces checking Betty's apical pulse for a full minute and her blood pressure, holding the dose and notifying the provider if either falls below her prescribed safe parameters.